• The Human Advantage

    Elevating women's health

Women's Health

Advanta Genetics has established itself as a leader in women's health through its innovative testing services and focus on precision diagnostics. The company's commitment to advancing women's health with specialized genetic and infectious disease testing is evident in its broad range of offerings, from sexually transmitted diseases and urogenital infections to genetic carrier screening and cancer risk assessments.

The use of Real-Time PCR technology for infectious agent detection highlights the company's dedication to accuracy and speed in diagnosis. This method's unrivaled sensitivity and specificity are critical in providing clinicians with timely and reliable results, which can be pivotal in guiding treatment decisions, identifying potential health risks early, and tailoring patient care effectively.



Women's Health Panel

Bacterial Targets
Atopobium vaginae
Bacterial Vaginosis-Associated Bacterium 1
Bacterial Vaginosis-Associated Bacterium 2
Bacterial Vaginosis-Associated Bacterium 3
Chlamydia trachomatis
Enterococcus faecalis
Enterococcus faecium
Gardnerella vaginalis
Haemophilus ducreyi
Lactobacillus
Megasphaera type I
Megasphaera type II
Mobiluncus curtisii
Mobiluncus mulieris
Mycoplasma genitalium
Neisseria gonorrhoeae
Treponema Pallidum
Ureaplasma urealyticum/parvum
Fungal Targets
Candida albicans
Candida glabrata
Escherichia coli
Sterptococcus agalactiae
Parasite Targets
Trichomonas vaginalis
Virus Targets
Herpes Simplex Virus 1 and 2
Resistance Genes
Aminoglycoside (ant-la)
Aminoglycoside (aph3)
Beta Lactamase (CTX-M-Grp1)
Beta Lactamase (SHV)
Beta Lactamase (TEM)
Carbapenem (KPC)
Carbapenem (NDM)
Carbapenem (OXA)
Fluoroquinolone (gyrA)
Fluoroquinolone (qnr)
Sulfonamide (Sul1)
Tetracycline (tetB)
Tetracycline (tetM)
Vancomycin (VanA)
Vancomycin (VanB)
Vancomycin (VanM)
Antimicrobial Agents PO IV IM PV SUP TOPIC
Aciclovir
Amoxicillin
Amoxicillin-Clavulanate
Amphotericin B
Amphotericin B
Ampicillin
Ampicillin
Azithromycin
Aztreonam
Aztreonam
Bacitracin
Bactrim
Bactrim DS
Cefazolin
Cefdinir
Ceftriaxone
Ceftriaxone
Ceftriaxone
Cefuroxime
Cephalexin
Ciprofloxacin
Clindamycin
Clindamycin cream 2%
Daptomycin
Daptomycin
Doxycycline
Erythromycin
Fluconazole
Flucytosine
Fosfomycin
Levofloxacin
Linezolid
Metronidazole
Metronidazole gel 0.75%
Micafungin
Moxifloxacin
Nitrofurantoin
Nitrofurantoin (macrobid)
No Medication (Suppressed)
Ofloxacin
Piperacillin - Tazobactam
Piperacillin - Tazobactam
TMP-SMX DS
Tripple Antibiotic Bac/Neo/Pol
Vancomycin
Vancomycin

Gonorrhoeae, Trichomonas, Chlamydia (GTC) Panel

Bacterial Targets
Chlamydia trachomatis
Neisseria gonorrhoeae
Parasite Targets
Trichomonas vaginalis
Antimicrobial Agents PO IV IM PV SUP TOPIC
Azithromycin
Ceftriaxone
Clindamycin
Clindamycin cream 2%
Doxycycline
Metronidazole
Metronidazole gel 0.75%

Test Limitations

This nucleic acid amplification test was developed, and its performance characteristics determined with polymerase chain reaction (PCR) by Advanta Genetics. This is a laboratory developed test and has not been cleared by the FDA. Advanta Genetics is regulated by CLIA as qualified to perform high complexity testing and is accredited by the College of America Pathologist (CAP). This test is for clinical purpose and should not be regarded as investigational or for research purposes.